GSK has snagged FDA approval for its 5-in-1 meningococcal vaccine, propelling it to a familiar position: rivaling Pfizer.
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Public Health said it investigated a case in a student last week at Cole Harbour High School. Close contacts were notified ...
Longtime anti-vaccine critic Robert F. Kennedy was confirmed Tuesday as the new Secretary of Health and Human Services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results